Verve Therapeutics Inc (VERV)
6.35
+0.31
(+5.13%)
USD |
NASDAQ |
Nov 05, 16:00
6.35
0.00 (0.00%)
After-Hours: 16:26
Verve Therapeutics Total Assets (Quarterly): 700.91M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 700.91M |
| March 31, 2024 | 732.36M |
| December 31, 2023 | 752.69M |
| September 30, 2023 | 612.41M |
| June 30, 2023 | 589.13M |
| March 31, 2023 | 634.38M |
| December 31, 2022 | 679.22M |
| September 30, 2022 | 673.36M |
| Date | Value |
|---|---|
| June 30, 2022 | 324.27M |
| March 31, 2022 | 349.24M |
| December 31, 2021 | 384.12M |
| September 30, 2021 | 410.88M |
| June 30, 2021 | 426.52M |
| March 31, 2021 | 158.17M |
| December 31, 2020 | 78.41M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
78.41M
Minimum
Dec 2020
752.69M
Maximum
Dec 2023
500.40M
Average
589.13M
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
| Ardelyx Inc | 367.86M |
| Biomarin Pharmaceutical Inc | 6.851B |
| Sage Therapeutics Inc | 622.43M |
| ALX Oncology Holdings Inc | 214.62M |
| Immuneering Corp | 77.09M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 154.82M |
| Shareholders Equity (Quarterly) | 546.09M |
| Current Ratio | 14.64 |